IMAC Holdings Inc. (IMAC) is a Medical Specialities company listed on NASDAQ. There were no new wire items for IMAC in the last 30 days. The most recent was published Jan 23, 2023.
Latest news
25 items- 13D/GSEC Form SC 13G filed by IMAC Holdings Inc.SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)
- SECSEC Form 10-Q filed by IMAC Holdings Inc.10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
- INSIDERSEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units4 - IMAC Holdings, Inc. (0001729944) (Issuer)
- INSIDERSEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units4 - IMAC Holdings, Inc. (0001729944) (Issuer)
- INSIDERSEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units4 - IMAC Holdings, Inc. (0001729944) (Issuer)
- SECSEC Form EFFECT filed by IMAC Holdings Inc.EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form S-3 filed by IMAC Holdings Inc.S-3 - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- 13D/GSEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)
- SECSEC Form D filed by IMAC Holdings Inc.D - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form 10-Q filed by IMAC Holdings Inc.10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form 424B5 filed by IMAC Holdings Inc.424B5 - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- NEWSIMAC Holdings Announces NASDAQ Ticker Symbol Change From 'IMAC' To 'BACK'IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022.
- PRIMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 16.4% to $1.42 during Tuesday's pre-market session. The company's market cap stands at $13.1 million. Vaccinex (NASDAQ:VCNX) stock rose 12.91% to $1.15. The company's market cap stands at $49.1 million. Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 12.49% to $4.05. The market value of their outstanding shares is at $38.0 million. Harmony Biosciences (NASDAQ:HRMY) shares moved upwards by 10.25% to $54.28. The market value of their outstanding shares is at $3.2 billion. As per the news, the Q2 earnings report came out today. Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 9.84% to $0.3. The company's market ca
- NEWSWhy Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market SessionGainers Dave Inc. (NASDAQ:DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. Pzena Investment Management, Inc (NYSE:PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales. Teva Pharmaceutical Industries Limited (NYSE:TEVA) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 18.1% to $0.31 in pre-market trading after declining more than 9% on Tuesday. AI
- NEWSIMAC Holdings Shares Resume Trading; Shares Up ~12% For Session
- NEWSIMAC Holdings Shares To Resume Trading At 9:50 a.m. EDT
- NEWSIMAC Holdings Announces Exploration Of Strategic Alternatives To Maximize Shareholder ValueIMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. “As our company continues to expand into complementary revenue streams, we believe the time is right to investigate a range of strategic
- PRIMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder ValueBRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe
- NEWSIMAC Holdings Shares Halted; News Pending
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers Addex Therapeutics (NASDAQ:ADXN) shares increased by 46.1% to $1.34 during Thursday's pre-market session. The company's market cap stands at $8.4 million. Tabula Rasa HealthCare (NASDAQ:TRHC) stock moved upwards by 14.61% to $2.98. The company's market cap stands at $77.0 million. MoonLake (NASDAQ:MLTX) stock rose 14.1% to $6.31. The market value of their outstanding shares is at $233.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 13.17% to $2.92. The market value of their outstanding shares is at $59.9 million. Olema Pharmaceuticals (NASDAQ:OLMA) shares increased by 10.4% to $5.2. The company's market cap stands at $209.8 million. Endo International (
IMAC FAQ
8 questionsWhat does IMAC Holdings Inc. do?
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. The company operates 16 outpatient clinics in Kentucky, Missouri, Tennessee, Illinois, and Florida. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.What is the latest news on IMAC?
Quantisnow has not tracked any new filings, ratings or press releases for IMAC in the last 30 days. The most recent wire item was published on January 23, 2023.Where does IMAC stock trade?
IMAC Holdings Inc. (IMAC) is listed on NASDAQ.What sector and industry is IMAC in?
IMAC Holdings Inc. operates in the Health Care sector, Medical Specialities industry.When did IMAC Holdings Inc. go public?
IMAC Holdings Inc. (IMAC) completed its IPO in 2019.What are analysts saying about IMAC?
Across the last 1 analyst actions on IMAC Holdings Inc., there were 0 upgrades and 1 downgrade. The most recent action was from National Alliance Securities: Neutral with a $1.75 price target on 2021-08-19. Recent price targets cluster around $1.75.What companies are similar to IMAC?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.), NTRA (Natera Inc.). Compare IMAC side-by-side with any of them on Quantisnow.How can I track IMAC on Quantisnow?
Quantisnow aggregates IMAC Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMAC to receive live email and push alerts on every new disclosure.